In a significant move underscoring the growing convergence of artificial intelligence and healthcare, Havas has announced a strategic investment and partnership with Ostro, an AI-powered engagement platform purpose-built for the life sciences industry. This alliance is set to redefine how healthcare brands engage both professionals and patients in a personalised, compliant, and scalable manner.
Redefining Healthcare Engagement
As healthcare professionals (HCPs) and patients face an overwhelming influx of information and options, there is a pressing need for more personalised, context-aware engagement. Ostro addresses this challenge by providing a seamless AI interface between life sciences companies, the medical community, and patients. The result is a tailored healthcare journey that improves health outcomes and maximises ROI for brands.
What sets Ostro apart is its ability to integrate into both branded and unbranded digital experiences, enabling dynamic, agent-led personalisation while adhering to strict compliance and regulatory standards. The platform boasts rapid implementation timelines—within eight weeks or less—making it an attractive solution for healthcare marketers seeking agility and scale.
A Strategic Evolution for Havas
“This partnership is a natural evolution of Havas’ Converged strategy,” said Yannick Bolloré, CEO and Chairman of Havas. “Ostro represents a significant leap forward in intelligent brand engagement and aligns with our Group’s commitment to invest €400 million in data, tech, and AI over four years.”
The collaboration will initially support Havas Health Network clients and is set to expand across Havas Creative and Media Networks. The aim is to power smarter content workflows, enhanced omnichannel activations, and increased media precision—ultimately elevating how brands connect with their audiences in healthcare settings.
Blending Creativity and Intelligence
Donna Murphy, Global CEO of Havas Health & Creative Networks, emphasized the creative potential of the partnership. “By combining creativity with AI-powered intelligence, we’re empowering clients to deliver relevant, personalised, and compliant brand experiences at scale. This partnership reflects our dedication to innovation in health and wellness marketing.”
Ostro’s functionality has already extended into medical affairs, and additional applications are currently in development. This includes capabilities that will further expand its ability to personalise engagement at every point in the healthcare journey.
The Vision Behind Ostro
“Ostro was built to make healthcare engagement more intuitive, contextual, and intelligent,” said Dr. Chase Feiger, CEO and Co-Founder of Ostro. “Partnering with Havas gives us the global reach and strategic support to scale our vision and push the boundaries of AI-led brand experiences.”
Ahmed Elsayyad, President and Co-Founder of Ostro, added, “This partnership enables us to scale agentic engagement—a model where interactions are no longer static or one-size-fits-all. Instead, Ostro’s technology delivers context-enabled responses that are adaptive and impactful throughout the healthcare experience.”
Looking Ahead
Advised by Houlihan Lokey, this strategic investment marks another major step in Havas’ journey toward a data- and technology-led future. By joining forces with Ostro, Havas is poised to help redefine the future of personalised healthcare marketing—where AI, creativity, and compliance converge to create meaningful, measurable outcomes.
